» Articles » PMID: 16843109

Low Frequency of Large Genomic Rearrangements of BRCA1 and BRCA2 in Western Denmark

Overview
Date 2006 Jul 18
PMID 16843109
Citations 17
Authors
Affiliations
Soon will be listed here.
Abstract

Germline mutations in BRCA1 and BRCA2 predispose female carriers to breast and ovarian cancer. The majority of mutations identified are small deletions or insertions or are nonsense mutations. Large genomic rearrangements in BRCA1 are found with varying frequencies in different populations, but BRCA2 rearrangements have not been investigated thoroughly. The objective in this study was to determine the frequency of large genomic rearrangements in BRCA1 and BRCA2 in a large group of Danish families with increased risk of breast and ovarian cancer. A total of 617 families previously tested negative for mutations involving few bases were screened with multiplex ligation-dependent probe amplification (MLPA). Two deletions in BRCA1 were identified in three families; no large rearrangements were detected in BRCA2. The large deletions constitute 3.8% of the BRCA1 mutations identified, which is low compared to several other populations.

Citing Articles

/ mutation spectrum analysis in South Asia: a systematic review.

Kharel S, Shrestha S, Yadav S, Shakya P, Baidya S, Hirachan S J Int Med Res. 2022; 50(1):3000605211070757.

PMID: 35000471 PMC: 8753086. DOI: 10.1177/03000605211070757.


Germline Structural Variations in Cancer Predisposition Genes.

Pocza T, Grolmusz V, Papp J, Butz H, Patocs A, Bozsik A Front Genet. 2021; 12:634217.

PMID: 33936164 PMC: 8081352. DOI: 10.3389/fgene.2021.634217.


Spectrum and prevalence of germline mutations in Pakistani breast cancer patients: results from a large comprehensive study.

Rashid M, Muhammad N, Naeemi H, Khan F, Hassan M, Faisal S Hered Cancer Clin Pract. 2019; 17:27.

PMID: 31528241 PMC: 6737632. DOI: 10.1186/s13053-019-0125-5.


BRCA1 and BRCA2 rearrangements in Brazilian individuals with Hereditary Breast and Ovarian Cancer Syndrome.

Ewald I, Cossio S, Palmero E, Pinheiro M, Nascimento I, Machado T Genet Mol Biol. 2016; 39(2):223-31.

PMID: 27303907 PMC: 4910561. DOI: 10.1590/1678-4685-GMB-2014-0350.


Screening for germline BRCA1, BRCA2, TP53 and CHEK2 mutations in families at-risk for hereditary breast cancer identified in a population-based study from Southern Brazil.

Palmero E, Alemar B, Schuler-Faccini L, Hainaut P, Moreira-Filho C, Ewald I Genet Mol Biol. 2016; 39(2):210-22.

PMID: 27223485 PMC: 4910552. DOI: 10.1590/1678-4685-GMB-2014-0363.